| abstract |
The present invention relates to sodium channel inhibitors of Formula (I): n n n n n n n n n n in which R 1 , R 2 , R 3 , R 4 , R 5 , X, Y, and Z are as defined herein, and to their use in the treatment of various disease states, including cardiovascular diseases and diabetes. n The invention also relates to methods for the preparation of the compounds, and to pharmaceutical compositions containing such compounds. |